# A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection

> **NCT00264446** · PHASE1 · COMPLETED · sponsor: **Adherex Technologies, Inc.**

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** ADH300004

## Key facts

- **NCT ID:** NCT00264446
- **Lead sponsor:** Adherex Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264446, "A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00264446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*